Publication & Citation Trends
Most Cited Works
Publications
113 total
The SGLT2 Inhibitor Canagliflozin Promotes β‐Cell Regeneration and Restores and Stabilises β‐Cell Identity in a Polygenic Model of Severe Early‐Onset Type 2 Diabetes
Cited by 0
Semantic Scholar
Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset. OA
Cited by 2
Semantic Scholar
Demographic variation in continuous glucose monitoring utilisation among patients with type 1 diabetes from a US regional academic medical centre: a retrospective cohort study, 2018–2021
Cited by 6
Semantic Scholar
IDF23-0543 Canagliflozin improves renal phenotype and restores beta-cell identity in an early-onset T2D model
Cited by 0
Semantic Scholar
Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019 OA
Cited by 22
Semantic Scholar
1396-P: Association between COVID-19 Infection and Incident Diabetes in Two Distinct Cohorts—A Nationwide Commercial Claims Database and a Regional Academic Medical Center
Cited by 0
Semantic Scholar
Physical activity patterns in adolescents and young adults with intellectual and developmental disabilities*
Cited by 0
Semantic Scholar
Research Topics
Growth Hormone and Insulin-like Growth Factors
(32)
Metabolism, Diabetes, and Cancer
(21)
Bone health and osteoporosis research
(17)
Diabetes Treatment and Management
(15)
Protease and Inhibitor Mechanisms
(15)
Frequent Co-Authors
Affiliations
University of Arkansas at Little Rock
Arkansas Children's Hospital
University of Kentucky
The University of Texas Health Science Center at San Antonio
Duke University